Andrew A. Hindman - 20 May 2021 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, Chief Financial Officer
Signature
Brett A. Grimaud as Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
20 May 2021
Net transactions value
-$16,768
Form type
4
Filing time
24 May 2021, 18:10:57 UTC
Next filing
24 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability $16,768 -942 -0.51% $17.80 184,844 20 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,082 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021.